These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 2620063)

  • 1. Contribution of the N-terminal region of hirudin to its interaction with thrombin.
    Wallace A; Dennis S; Hofsteenge J; Stone SR
    Biochemistry; 1989 Dec; 28(26):10079-84. PubMed ID: 2620063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of fragments of hirudin to investigate thrombin-hirudin interaction.
    Dennis S; Wallace A; Hofsteenge J; Stone SR
    Eur J Biochem; 1990 Feb; 188(1):61-6. PubMed ID: 2180697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of the N-terminal region of hirudin with the active-site cleft of thrombin.
    Betz A; Hofsteenge J; Stone SR
    Biochemistry; 1992 May; 31(19):4557-62. PubMed ID: 1581311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of site-directed mutagenesis to investigate the basis for the specificity of hirudin.
    Braun PJ; Dennis S; Hofsteenge J; Stone SR
    Biochemistry; 1988 Aug; 27(17):6517-22. PubMed ID: 3146347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of the inhibition of alpha-thrombin by hirudin-derived fragments hirudin(1-47) and hirudin(45-65).
    Schmitz T; Rothe M; Dodt J
    Eur J Biochem; 1991 Jan; 195(1):251-6. PubMed ID: 1991472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH dependence of the interaction of hirudin with thrombin.
    Betz A; Hofsteenge J; Stone SR
    Biochemistry; 1992 Feb; 31(4):1168-72. PubMed ID: 1734964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-activity relationships of recombinant hirudins.
    Stürzebecher J; Walsmann P
    Semin Thromb Hemost; 1991 Apr; 17(2):94-8. PubMed ID: 1771418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-function relationships of the C-terminal functional domain of hirudin and its variants.
    Krstenansky JL; Mao SJ
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):91-6. PubMed ID: 1773003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-function and refolding studies of the thrombin-specific inhibitor hirudin.
    Johnson PH; Sze P; Winant RC; Hudson D; Underhill P; Lazar JB; Olsen C; Almquist R
    Haemostasis; 1991; 21 Suppl 1():41-8. PubMed ID: 1894196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interaction of hirudin with thrombin: identification of a minimal binding domain of hirudin that inhibits clotting activity.
    Mao SJ; Yates MT; Owen TJ; Krstenansky JL
    Biochemistry; 1988 Oct; 27(21):8170-3. PubMed ID: 3233202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of interactions involving C-terminal nonpolar residues of hirudin in the formation of the thrombin-hirudin complex.
    Betz A; Hofsteenge J; Stone SR
    Biochemistry; 1991 Oct; 30(41):9848-53. PubMed ID: 1911777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probing the hirudin-thrombin interaction by incorporation of noncoded amino acids and molecular dynamics simulation.
    De Filippis V; Colombo G; Russo I; Spadari B; Fontana A
    Biochemistry; 2002 Nov; 41(46):13556-69. PubMed ID: 12427016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of hirudin with the dysthrombins Quick I and II.
    Stone SR; Schmitz T; Henriksen RA; Hofsteenge J; Dodt J
    Biochemistry; 1991 Jul; 30(26):6392-7. PubMed ID: 2054344
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The C-terminal binding domain of hirullin P18. Antithrombin activity and comparison to hirudin peptides.
    Krstenansky JL; Owen TJ; Yates MT; Mao SJ
    FEBS Lett; 1990 Sep; 269(2):425-9. PubMed ID: 2401369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrostatic steering and ionic tethering in the formation of thrombin-hirudin complexes: the role of the thrombin anion-binding exosite-I.
    Myles T; Le Bonniec BF; Betz A; Stone SR
    Biochemistry; 2001 Apr; 40(16):4972-9. PubMed ID: 11305913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hirudin: amino-terminal residues play a major role in the interaction with thrombin.
    Lazar JB; Winant RC; Johnson PH
    J Biol Chem; 1991 Jan; 266(2):685-8. PubMed ID: 1985956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CX-397, a novel recombinant hirudin analog having a hybrid sequence of hirudin variants-1 and -3.
    Komatsu Y; Misawa S; Sukesada A; Ohba Y; Hayashi H
    Biochem Biophys Res Commun; 1993 Oct; 196(2):773-9. PubMed ID: 8240353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative evaluation of the contribution of ionic interactions to the formation of the thrombin-hirudin complex.
    Stone SR; Dennis S; Hofsteenge J
    Biochemistry; 1989 Aug; 28(17):6857-63. PubMed ID: 2819038
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reevaluating the effects of tyrosine iodination of recombinant hirudin on its thrombin inhibition kinetics.
    Komatsu Y; Hayashi H
    Thromb Res; 1997 Aug; 87(4):343-52. PubMed ID: 9271811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of site specific amino acid exchanges in hirudin on the thrombin-hirudin interaction.
    Köhler S; Dodt J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):24-9. PubMed ID: 2459027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.